Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baidu
BIDU
|
+$462M |
| 2 |
AGN
Allergan plc
AGN
|
+$390M |
| 3 |
AT&T
T
|
+$371M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$353M |
| 5 |
NextEra Energy
NEE
|
+$326M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.97B |
| 2 |
Meta Platforms (Facebook)
META
|
+$435M |
| 3 |
Pfizer
PFE
|
+$377M |
| 4 |
GE Aerospace
GE
|
+$354M |
| 5 |
Starbucks
SBUX
|
+$323M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 25.43% |
| 2 | Technology | 12.71% |
| 3 | Consumer Staples | 9.79% |
| 4 | Financials | 8.2% |
| 5 | Utilities | 8.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
STMP
2776
DELISTED
Stamps.com, Inc.
STMP
| $481K | ﹤0.01% |
+3,700
| New | +$388K |
|
|
STAB
2777
DELISTED
Statera Biopharma, Inc. Common Stock
STAB
| $480K | ﹤0.01% |
289,351
-21,165
| -7% | -$43.2K |
|
2778
China Pharma Holdings
CPHI
$49M
| $479K | ﹤0.01% |
1,900
+113
| +6% | +$29.8K |
|
2779
Fuel Tech
FTEK
$42.8M
| $477K | ﹤0.01% |
1,191,538
+5,300
| +0.4% | +$4.07K |
|
2780
Direxion Daily Financial Bull 3x ETF
FAS
$2.47B
| $474K | ﹤0.01% |
+20,200
| New | +$1.54M |
|
|
CTHR
2781
DELISTED
Charles & Colvard Ltd
CTHR
| $474K | ﹤0.01% |
70,077
-1,384
| -2% | -$15K |
|
2782
Gevo
GEVO
$351M
| $473K | ﹤0.01% |
576,533
+1,239
| +0.2% | +$2.13K |
|
2783
Mid Penn Bancorp
MPB
$957M
| $472K | ﹤0.01% |
23,306
-12,468
| -35% | -$294K |
|
2784
Tennant Co
TNC
$1.31B
| $472K | ﹤0.01% |
+8,145
| New | +$601K |
|
|
AGFS
2785
DELISTED
AgroFresh Solutions Inc
AGFS
| $472K | ﹤0.01% |
288,004
+49,916
| +21% | +$107K |
|
2786
Baytex Energy
BTE
$2.93B
| $471K | ﹤0.01% |
2,016,797
+1,204,848
| +148% | +$1.11M |
|
|
DSKE
2787
DELISTED
Daseke, Inc. Common Stock
DSKE
| $471K | ﹤0.01% |
336,497
+21,700
| +7% | +$64K |
|
2788
Silicom
SILC
$239M
| $470K | ﹤0.01% |
17,400
-8,158
| -32% | -$259K |
|
|
DZSI
2789
DELISTED
DZS Inc. Common Stock
DZSI
| $470K | ﹤0.01% |
112,190
-33,907
| -23% | -$259K |
|
|
IEA
2790
DELISTED
Infrastructure and Energy Alternatives, Inc. Common Stock
IEA
| $468K | ﹤0.01% |
232,933
+13,100
| +6% | +$39.2K |
|
2791
ProShares Ultra Energy
DIG
$78.9M
| $467K | ﹤0.01% |
+77,440
| New | +$1.6M |
|
2792
United Natural Foods
UNFI
$2.9B
| $467K | ﹤0.01% |
50,912
-925,550
| -95% | -$7.34M |
|
2793
Madison Square Garden
MSGS
$9.43B
| $465K | ﹤0.01% |
+3,084
| New | +$598K |
|
2794
CorMedix
CRMD
$589M
| $463K | ﹤0.01% |
128,900
+72,500
| +129% | +$410K |
|
2795
Kelly Services Class A
KELYA
$542M
| $462K | ﹤0.01% |
+36,398
| New | +$634K |
|
2796
iShares MSCI Italy ETF
EWI
$1.07B
| $461K | ﹤0.01% |
22,200
+5,500
| +33% | +$147K |
|
|
HIL
2797
DELISTED
Hill International, Inc. Common Stock
HIL
| $460K | ﹤0.01% |
317,389
+5,700
| +2% | +$16.3K |
|
2798
Red Violet
RDVT
$950M
| $459K | ﹤0.01% |
25,500
-17,900
| -41% | -$368K |
|
2799
AYTU BioPharma
AYTU
$25M
| $458K | ﹤0.01% |
+1,528
| New | +$295K |
|
2800
Griffon
GFF
$4.88B
| $457K | ﹤0.01% |
36,100
-63,700
| -64% | -$1.15M |
|
Similar funds
Renaissance Technologies's Q1 2020 Portfolio in Review
As of Q1 2020, Renaissance Technologies held 4,047 positions worth $103B, down 21% from $130B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Renaissance Technologies's Q1 2020 filing shows 573 new, 1,474 increased, 1,328 reduced and 645 closed positions. Its largest new stake was AT&T: 13,563,699 shares worth $299M. The largest sale was Tesla, an estimated $1.97B.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 21% a quarter earlier, followed by Technology and Consumer Staples.
- Renaissance Technologies's largest Q1 2020 buy was AT&T: 13,563,699 shares worth $299M.
- Renaissance Technologies added most to Baidu in Q1 2020, an estimated $462M increase.
- Renaissance Technologies's biggest Q1 2020 reduction was Tesla, cutting an estimated $1.97B.
- Renaissance Technologies fully exited Phillips 66 in Q1 2020, selling an estimated $214M.
- Renaissance Technologies's ten largest holdings make up 15% of its $103B portfolio in Q1 2020.
- Renaissance Technologies opened 573 new positions and closed 645 in Q1 2020.
- Renaissance Technologies's portfolio value fell 21% quarter-over-quarter to $103B.
Based on Renaissance Technologies's 13F filing for Q1 2020, filed 14 May 2020.